Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling
Yang Qin(Southern Medical University), Lixia Mo(Southern Medical University), Yiyuan Wang(Southern Medical University), Binhua Zou(Southern Medical University), Qinghe Liang(Southern Medical University), Fengsheng Chen(TCM-Intigrated Cancer Center of Southern Medical University), Jingyun Guo(Nanfang Hospital), Ziye Chen(Southern Medical University), Zongbao Ding(Southern Medical University), Yan Chen(Sun Yat-sen University), Xiaojuan Li(Guilin Medical University), Lihong Li(Southern Medical University), Ruopeng Li(Southern Medical University), Jiehuang Zheng(Guangdong Pharmaceutical University)
Cited by 14
Related Papers
Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota
|Journal of the American Chemical Society|2023|177
Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
|Acta Pharmaceutica Sinica B|2021|158
Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer
|Nano Research|2020|145
Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway
|Acta Pharmacologica Sinica|2019|120
Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models
|Chinese Chemical Letters|2020|97